Dr Judy Garber - Dana Farber Cancer Institute, Boston, USA
Dr Judy Garber, speaking at AACR 2010, talks about the STAR trial, which looked at tamoxifen versus raloxifene as preventive treatment to lower breast cancer risk in high risk post-menopausal women.